Boston Scientific Overview
Latest P/E ratio for Boston Scientific: 17.48 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow17.48
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Boston Scientific (BSX) currently reports a P/E ratio of 17.48. That is below the Healthcare sector average of 25.3. Use the charts on this page to explore Boston Scientific's P/E ratio history and peer comparisons.
Boston Scientific's P/E ratio of 17.48 is lower than the Healthcare sector average of 25.3. That is roughly 30.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Boston Scientific's market price to a fundamental measure such as earnings, sales, or book value. At 17.48, BSX can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 17.48, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.3. From there, open related valuation or income-statement pages for Boston Scientific, and consider following BSX for alerts when major investors trade the stock.
Boston Scientific is classified in the Healthcare sector. On P/E ratio, it currently shows 17.48 versus a sector average near 25.3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BSX with unrelated industries.
